RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists

Clinical trial NCT02112565 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT02112565

Sponsor

City of Hope Medical Center

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2016-06-13

Primary completion

2018-11-23

Enrollment

12

View on ClinicalTrials.gov